Panel discussion and Q&A

5 More presentations in this session

Welcome and introductions: cardiovascular risk in people with type 2 diabetes and/or obesity

Professor N. Marx (Aachen, DE)

The effect of GLP-1RAs on cardiovascular disease and cardio-metabolic risk factors in patients with obesity and/or type 2 diabetes

Professor S. Verma (Toronto, CA)

GLP-1RAs: what does the future hold?

Doctor T. Vilsboll (Copenhagen, DK)

A focus on the practical: how can cardiologists best utilise GLP-1RAs in the clinic?

Professor N. Marx (Aachen, DE)

Closing

Professor N. Marx (Aachen, DE)